- Report
- October 2025
- 192 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- October 2025
- 280 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- January 2025
- 95 Pages
Global
From €3500EUR$4,215USD£3,147GBP
- Report
- October 2025
- 184 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- October 2025
- 199 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 183 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 195 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 192 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 196 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 198 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 189 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 184 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 180 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 192 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 189 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 190 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- October 2025
- 371 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 379 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 164 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- September 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,470GBP

The antiretroviral market is a subset of the HIV/AIDS drugs market, which is focused on the development and sale of drugs that can be used to treat HIV/AIDS. Antiretroviral drugs are used to reduce the amount of HIV in the body, and can be used to prevent the transmission of HIV from one person to another. These drugs are typically used in combination with other treatments, such as counseling and lifestyle changes, to help people living with HIV/AIDS manage their condition.
The antiretroviral market is highly competitive, with many companies developing and selling drugs to treat HIV/AIDS. Some of the major players in the market include Gilead Sciences, Merck, Bristol-Myers Squibb, GlaxoSmithKline, and ViiV Healthcare. Other companies, such as AbbVie, Janssen, and Mylan, also have a presence in the market. Show Less Read more